Intra-golgi formation of IgM-glycosaminoglycan complexes promotes Ig deposition

Journal of Immunology

Volumn 187, Issue 6, 2011, Pages 3198-3207

  Khan, Salar N ^a   Cox, John V ^a   Nishimoto, Satoru K ^a   Chen, Ching ^b   Fritzler, Marvin J ^c   Hendershot, Linda M ^a,d   Weigert, Martin ^e,f   Radic, Marko ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

^f UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN ABC LYASE; ENDOGLYCOSIDASE H; GLYCAN; GLYCOSAMINOGLYCAN; GLYCOSIDASE; HEPARIN; HYALURONIC ACID; IMMUNOGLOBULIN J CHAIN; IMMUNOGLOBULIN M; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL LEVEL; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVITY; GOLGI COMPLEX; HYBRIDOMA; IMMUNOGLOBULIN DEPOSITION; INTRACELLULAR TRANSPORT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEOGLYCAN SYNTHESIS;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; BLOTTING, WESTERN; FLUORESCENT ANTIBODY TECHNIQUE; GLYCOSAMINOGLYCANS; GOLGI APPARATUS; IMMUNE COMPLEX DISEASES; IMMUNOBLOTTING; IMMUNOGLOBULIN M; MICE; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION;

EID: 80053080678     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101336     Document Type: Article

References (46)

1. Nossal, G. J. 1983. Cellular mechanisms of immunologic tolerance. Annu. Rev. Immunol. 1: 33-62.
2. Shlomchik, M. J. 2008. Sites and stages of autoreactive B cell activation and regulation. Immunity 28: 18-28.
3. Nemazee, D. 2006. Receptor editing in lymphocyte development and central tolerance. Nat. Rev. Immunol. 6: 728-740.
4. Casellas, R., Q. Zhang, N. Y. Zheng, M. D. Mathias, K. Smith, and P. C. Wilson. 2007. Igk allelic inclusion is a consequence of receptor editing. J. Exp. Med. 204: 153-160.
5. Li, Y., H. Li, and M. Weigert. 2002. Autoreactive B cells in the marginal zone that express dual receptors. J. Exp. Med. 195: 181-188.
6. Liu, S., M. G. Velez, J. Humann, S. Rowland, F. J. Conrad, R. Halverson, R. M. Torres, and R. Pelanda. 2005. Receptor editing can lead to allelic inclusion and development of B cells that retain antibodies reacting with high avidity autoantigens. J. Immunol. 175: 5067-5076.
7. Khan, S. N., E. J. Witsch, N. G. Goodman, A. K. Panigrahi, C. Chen, Y. Jiang, A. M. Cline, J. Erikson, M. Weigert, E. T. Prak, and M. Radic. 2008. Editing and escape from editing in anti-DNA B cells. Proc. Natl. Acad. Sci. USA 105: 3861-3866.
8. Agnello, V., D. Koffler, and H. G. Kunkel. 1973. Immune complex systems in the nephritis of systemic lupus erythematosus. Kidney Int. 3: 90-99.
9. Waldman, M., and M. P. Madaio. 2005. Pathogenic autoantibodies in lupus nephritis. Lupus 14: 19-24.
10. Pisetsky, D. S. 2004. DNA as a marker of cell death in systemic lupus erythematosus. Rheum. Dis. Clin. North Am. 30: 575-587.
11. Winfield, J. B., I. Faiferman, and D. Koffler. 1977. Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus: association of high avidity antinative DNA antibody with glomerulonephritis. J. Clin. Invest. 59: 90-96.
12. Berden, J. H., R. Licht, M. C. Van Bruggen, and W. J. Tax. 1999. Role of nucleosomes for induction and glomerular binding of autoantibodies in lupus nephritis. Curr. Opin. Nephrol. Hypertens. 8: 299-306.
13. Sabbaga, J., S. R. Line, P. Potocnjak, and M. P. Madaio. 1989. A murine nephritogenic monoclonal anti-DNA autoantibody binds directly to mouse laminin, the major non-collagenous protein component of the glomerular basement membrane. Eur. J. Immunol. 19: 137-143.
14. Heher, E. C., N. B. Goes, T. R. Spitzer, N. S. Raje, B. D. Humphreys, K. C. Anderson, and P. G. Richardson. 2010. Kidney disease associated with plasma cell dyscrasias. Blood 116: 1397-1404.
15. Wechalekar, A. D., H. J. Lachmann, H. J. Goodman, A. Bradwell, P. N. Hawkins, and J. D. Gillmore. 2008. AL amyloidosis associated with IgM paraproteinemia: clinical profile and treatment outcome. Blood 112: 4009-4016.
16. Shaheen, S. P., S. S. Talwalkar, and L. J. Medeiros. 2008. Multiple myeloma and immunosecretory disorders: an update. Adv. Anat. Pathol. 15: 196-210.
17. Gu, M., R. Wilton, and F. J. Stevens. 2007. Diversity and diversification of light chains in myeloma: the specter of amyloidogenesis by proxy. Contrib. Nephrol. 153: 156-181.
18. Baden, E. M., E. G. Randles, A. K. Aboagye, J. R. Thompson, and M. Ramirez- Alvarado. 2008. Structural insights into the role of mutations in myloidogenesis. J. Biol. Chem. 283: 30950-30956.
19. Iannuzzella, F., A. Vaglio, and G. Garini. 2010. Management of hepatitis C virus-related mixed cryoglobulinemia. Am. J. Med. 123: 400-408.
20. Stevens, F. J., and R. Kisilevsky. 2000. Immunoglobulin light chains, glycosaminoglycans, and amyloid. Cell. Mol. Life Sci. 57: 441-449.
21. Haimovich, J., T. Kukulansky, B. Weissman, and N. Hollander. 1999. Rejection of tumors of the B cell lineage by idiotype-vaccinated mice. Cancer Immunol. Immunother. 47: 330-336.
22. Taussig, M. J., A. Holliman, and L. J. Wright. 1980. Hybridization between T and B lymphoma cell lines. Immunology 39: 57-60.
23. Nozawa, K., M. J. Fritzler, C. A. Von Mühlen, and E. K. Chan. 2004. Giantin is the major Golgi autoantigen in human anti-Golgi complex sera. Arthritis Res. Ther. 6: R95-R102.
24. Bergman, Y., J. Haimovich, and F. Melchers. 1977. An IgM-producing tumor with biochemical characteristics of a small B lymphocyte. Eur. J. Immunol. 7: 574-579.
25. Hasbold, J., and G. G. Klaus. 1990. Anti-immunoglobulin antibodies induce apoptosis in immature B cell lymphomas. Eur. J. Immunol. 20: 1685-1690.
26. Harter, C. 1995. COP-coated vesicles in intracellular protein transport. FEBS Lett. 369: 89-92.
27. Fritzler, M. J., J. C. Hamel, R. L. Ochs, and E. K. Chan. 1993. Molecular characterization of two human autoantigens: unique cDNAs encoding 95- and 160- kD proteins of a putative family in the Golgi complex. J. Exp. Med. 178: 49-62.
28. Shah, N., D. A. Kuntz, and D. R. Rose. 2008. Golgi a-mannosidase II cleaves two sugars sequentially in the same catalytic site. Proc. Natl. Acad. Sci. USA 105: 9570-9575.
29. Valetti, C., and R. Sitia. 1994. The differential effects of dithiothreitol and 2-mercaptoethanol on the secretion of partially and completely assembled immunoglobulins suggest that thiol-mediated retention does not take place in or beyond the Golgi. Mol. Biol. Cell 5: 1311-1324.
30. Brewer, J. W., T. D. Randall, R. M. Parkhouse, and R. B. Corley. 1994. Mechanism and subcellular localization of secretory IgM polymer assembly. J. Biol. Chem. 269: 17338-17348.
31. Thyberg, J., and S. Moskalewski. 1985. Microtubules and the organization of the Golgi complex. Exp. Cell Res. 159: 1-16.
32. Buxbaum, J. N. 2003. Diseases of protein conformation: what do in vitro experiments tell us about in vivo diseases? Trends Biochem. Sci. 28: 585-592.
33. Anelli, T., S. Ceppi, L. Bergamelli, M. Cortini, S. Masciarelli, C. Valetti, and R. Sitia. 2007. Sequential steps and checkpoints in the early exocytic compartment during secretory IgM biogenesis. EMBO J. 26: 4177-4188.
34. Brewer, J. W., and R. B. Corley. 1997. Late events in assembly determine the polymeric structure and biological activity of secretory IgM. Mol. Immunol. 34: 323-331.
35. Carlsson, P., J. Presto, D. Spillmann, U. Lindahl, and L. Kjellén. 2008. Heparin/ heparan sulfate biosynthesis: processive formation of N-sulfated domains. J. Biol. Chem. 283: 20008-20014.
36. Kjellén, L., and U. Lindahl. 1991. Proteoglycans: structures and interactions. Annu. Rev. Biochem. 60: 443-475.
37. Bret, C., D. Hose, T. Reme, A. C. Sprynski, K. Mahtouk, J. F. Schved, P. Quittet, J. F. Rossi, H. Goldschmidt, and B. Klein. 2009. Expression of genes encoding for proteins involved in heparan sulphate and chondroitin sulphate chain synthesis and modification in normal and malignant plasma cells. Br. J. Haematol. 145: 350-368.
38. Shi, X., and J. Zaia. 2009. Organ-specific heparan sulfate structural phenotypes. J. Biol. Chem. 284: 11806-11814.
39. Li, H., Y. Jiang, E. L. Prak, M. Radic, and M. Weigert. 2001. Editors and editing of anti-DNA receptors. Immunity 15: 947-957.
40. Xu, H., H. Li, E. Suri-Payer, R. R. Hardy, and M. Weigert. 1998. Regulation of anti-DNA B cells in recombination-activating gene-deficient mice. J. Exp. Med. 188: 1247-1254.
41. Bai, L., Y. Chen, Y. He, X. Dai, X. Lin, R. Wen, and D. Wang. 2007. Phospholipase Cg2 contributes to light-chain gene activation and receptor editing. Mol. Cell. Biol. 27: 5957-5967.
42. Hayashi, K., T. Nojima, R. Goitsuka, and D. Kitamura. 2004. Impaired receptor editing in the primary B cell repertoire of BASH-deficient mice. J. Immunol. 173: 5980-5988.
43. Cadera, E. J., F. Wan, R. H. Amin, H. Nolla, M. J. Lenardo, and M. S. Schlissel. 2009. NF-kB activity marks cells engaged in receptor editing. J. Exp. Med. 206: 1803-1816.
44. Pathak, S., S. Ma, L. Trinh, and R. Lu. 2008. A role for interferon regulatory factor 4 in receptor editing. Mol. Cell. Biol. 28: 2815-2824.
45. Köhler, F., B. Storch, Y. Kulathu, S. Herzog, S. Kuppig, M. Reth, and H. Jumaa. 2005. A leucine zipper in the N terminus confers membrane association to SLP- 65. Nat. Immunol. 6: 204-210.
46. Chen, C., H. Li, Q. Tian, M. Beardall, Y. Xu, N. Casanova, and M. Weigert. 2006. Selection of anti-double-stranded DNA B cells in autoimmune MRL-lpr/lpr mice. J. Immunol. 176: 5183-5190.